Guru Ownership Trend
Guru Analysis for Maze Therapeutics, Inc. (MAZE)
Maze Therapeutics, Inc. (MAZE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.26 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $1.45 M net outflow during the quarter.
Recent activity highlights Paul Tudor Jones who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 68.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Maze Therapeutics, Inc. (MAZE)
Major holders include Cliff Asness ($1.14 M), Renaissance Technologies (RenTech) ($1.12 M), Paul Tudor Jones ($996,764). According to the latest reported data, 3 tracked investment managers collectively hold approximately 78,598 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $1.45 M, with 1 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 0 fully exited MAZE. The total reported sell value was $2.45 M.
Yes, 1 managers opened new positions in MAZE, and 0 increased their existing holdings. The total reported buy value was $996,764.